Abstract
We describe the evaluation of the EMIT®2000 cyclosporine specific assay kit, an enzyme‐multiplied immunoassay for cyclosporine in whole blood, with a COBAS MIRA‐plus analyzer. The enzyme used for the assay was glucose‐6‐phosphate dehydrogenase (EC 1.1.1.49 G6PDH) from Leuconostoc mesenteroides; the monoclonal antibody is fairly specific for cyclosporine, and is not reactive with most metabolites. The assay principle is based on competitive immunoassay with G6PDH‐labeled cyclosporine and cyclosporine in sample to the anticyclosporine mouse monoclonal antibody binding site. The within‐assay coefficient of variation (CV) of this method was 2.7–4.2% (n = 10) at the levels of 56.2–339.7 μg/L. Day‐to‐day CVs ranged from 4.2–8.1% at the levels of 47.2–350.2 μg/L. The within‐day CVs ranged from 2.0–6.4% at the levels of 43.3–330.5 μg/L. The functional detection limit was 24.9 μg/L. Samples treated with pretreatment reagent were stable at least 5 hr. Calibration was stable at least 10 days. The analytical recovery was 81–109%. The correlation between values obtained with the EMIT®2000 cyclosporine specific assay kit (y) and fluorescence polarization immunoassay (FPIA) (TDxFLx) (x) was: y = 0.880x – 13.053 μg/L (r = 0.984, Sy/x = 15.968, n = 71) with a mean difference of 31.42 ± 19.89 μg/L ((TDxFLx – EMIT®2000) ± SD); for the FPIA (AxSYM) (x): y = 0.989 – 4.144 μg/L (r = 0.981, Sy/x = 17.478, n = 71) with a mean difference of 5.56 ± 17.38 μg/L ((AxSYM – EMIT®2000) ± SD); and for the radioimmunoassay (RIA, CYCLO‐Trac SP) (x): y = 0.893 – 6.764 μg/L (r = 0.993, Sy/x = 10.582, n = 71) with a mean difference of 22.18 ± 14.98 μg/L ((RIA – EMIT®2000) ± SD) using the Bland‐Altman technique. J. Clin. Lab. Anal. 15:319–323, 2001. © 2001 Wiley‐Liss, Inc.
Keywords: cyclosporine, homogenous enzyme immunoassay, glucose‐6‐phosphate dehydrogenase, method comparison
REFERENCES
- 1. White DJG. 1982. Cyclosporin A: Clinical pharmacology and therapeutic potential. Drugs 24:322–334. [DOI] [PubMed] [Google Scholar]
- 2. Stein CM, Murray JJ, Wood AJJ. 1999. Inhibition of stimulated interleukin‐2 production in whole blood: a practical measure of cyclosporine effect. Clin Chem 45:1477–1484. [PubMed] [Google Scholar]
- 3. Kalman VK, Klimpel GR. 1983. Cyclosporine A inhibits the production of gamma interferon (IFNγ) but does not inhibit production of virus‐induced IFNα/β . Cell Immunol 78:122–129. [DOI] [PubMed] [Google Scholar]
- 4. Shaw LM, Kaplan B, Kaufman D. 1996. Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clin Chem 42:1316–1321. [PubMed] [Google Scholar]
- 5. Gupta SK, Benet LZ. 1989. HPLC measurement of cyclosporine in blood, plasma and urine and simultaneous measurement of its four metabolites in blood. J Liq Chromatogr 12:1451–1462. [Google Scholar]
- 6. Yatscoff RW, Copeland KR, Faracl CJ. 1990. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem 36:1969–1973. [PubMed] [Google Scholar]
- 7. Schutz E, Svinarov D, Shipkova M, et al. 1998. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): A critical overview of performance characteristics and comparison with HPLC. Clin Chem 44:2158–2164. [PubMed] [Google Scholar]
- 8. Lee SC, Brudzinski AM, Yasmineh JL, et al. 1991. Measurement of cyclosporine A by a specific radioimmunoassay with a monoclonal antibody and 125I tracer. Clin Biochem 24:43–48. [DOI] [PubMed] [Google Scholar]
- 9. Dias VC, Legatt D, Yatscoff RW. 1997. The EMIT® cyclosporine assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers. Clin Biochem 30:155–162. [DOI] [PubMed] [Google Scholar]
- 10. Wallemacq PE, Lee SC, Lhoest G, Hassoun A. 1990. Cross‐reactivity of cyclosporine metabolites in two different radioimmunoassays in which the same specific monoclonal antibody is used. Clin Chem 36:385. [PubMed] [Google Scholar]
- 11. Pfeiffer M, Leaver N, Ail R, et al. 1996. Syva Emit® cyclosporine assay—a novel whole blood pretreatment reagent. Clin Chem 42(abstr):S227. [Google Scholar]
- 12. Steier W. 1999. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem 45:371–378. [PubMed] [Google Scholar]
- 13. Kovarik JM, Vernillet L, Mueller EA, Freiburghaus R, Niederberger W, Kutz K. 1994. Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation. Ther Drug Monit 16:519–525. [DOI] [PubMed] [Google Scholar]
- 14. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310. [PubMed] [Google Scholar]